Abstract
This study aimed to examine how biomarker information would impact patients’ preferences and physicians’ recommendations for adjuvant breast cancer therapy.
Funding Information
  • National Cancer Institute (CA21115, CA180820, CA180821, CA077651, CA49883, CA13650, CA180794, CA180795, CA180816, CA180790, CA180867, CA180791, CA23318, CA031946, CA025224, CA66636)
  • Susan G. Komen for the Cure (Promise Award)

This publication has 12 references indexed in Scilit: